The ATG5-dependency of TRAF3 levels and transcriptional events were also demonstrated by CRISPR-Cas9 deletion of ATG5 in a second RAS-mutant lung cancer line, NCI-H23 (Fig. 4f, Supplementary Fig. 6a). Here, TRAF3 is linked to lung carcinoma.